The Chinese government has been encouraging overseas pharmaceutical companies to outsource R&D to Chinese firms—part of an effort to move into more high-value work. The draw: a growing, cost-effective bioscience talent pool made up of both local graduates and “sea turtles” who went to U.S. universities and returned, according to Morrison & Foerster partner Gordon… Continue Reading
Tag Archives: China
Maximizing Mergers and Acquisitions: An in-depth look behind the headlines at some important emerging trends
Posted on from MoFo Tech Fall/Winter 2011Mergers and acquisitions are back in the headlines. Following two years of sharp decline, deal making increased 12 percent in 2010, according to Bloomberg. Cross-border deals shot up 41 percent. With companies sitting on record cash war chests, the trend looks likely to continue. A small sampling of recent activity: Sanofi-Aventis completed its $20.1 billion… Continue Reading